2004
DOI: 10.1163/156856204323046861
|View full text |Cite
|
Sign up to set email alerts
|

Amido-modified polylactide for potential tissue engineering applications

Abstract: Poly(ester amide) copolymers based on L-lactide (2) and a new depsipeptide (1) were prepared by ring opening polymerization in the presence of Sn(Oct)2 as the catalyst. Variable monomer feed ratios up to 2.3 mol% 1 afforded copolymers containing ester and amido functional groups in the backbone. Lower glass transition temperatures and reduced crystallization kinetics and crystallinity compared to homo-polylactide (PLA) was achieved with low levels of amido incorporation. A reactivity comparison between enchain… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2007
2007
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(14 citation statements)
references
References 18 publications
0
14
0
Order By: Relevance
“…Typically, polylactide and polyglycolide are the most widely used polymers due to their mild inflammatory response, complete biodegradability, and Food and Drug Administrative approval for a variety of applications. However, polymeric biomaterials typically do not promote high levels of cellular attachment without either surface modification or the incorporation of a secondary material such as β-TCP, when compared with extracellular matrix based materials [109]. In vitro tissue engineering has shown poly-L-lactide-co-glycolide to be capable of allowing mineralization and osteogenic differentiation, as detected through histological and molecular characterization [85,110,111].…”
Section: Biomaterialsmentioning
confidence: 99%
“…Typically, polylactide and polyglycolide are the most widely used polymers due to their mild inflammatory response, complete biodegradability, and Food and Drug Administrative approval for a variety of applications. However, polymeric biomaterials typically do not promote high levels of cellular attachment without either surface modification or the incorporation of a secondary material such as β-TCP, when compared with extracellular matrix based materials [109]. In vitro tissue engineering has shown poly-L-lactide-co-glycolide to be capable of allowing mineralization and osteogenic differentiation, as detected through histological and molecular characterization [85,110,111].…”
Section: Biomaterialsmentioning
confidence: 99%
“…Versatile polydepsipeptides, with or without pendant functional groups, can be synthesized via ROP of various morpholine‐2,5‐dione derivatives. Polydepsipeptides are potential candidates for a wide range of biomedical applications 27, 41–43…”
Section: Synthesis Of Biodegradable Polymer Derived From Amino Acidsmentioning
confidence: 99%
“…These polymers exhibited in vitro and in vivo biocompatibility and had projected degradation half‐lives of up to 20 months in vivo. Abayasinghe et al prepared PEA copolymers based on L‐lactide and a new depsipeptide were prepared by ROP in the presence of Sn(Oct) 2 as the catalyst 42. Preliminary results indicate that these novel materials exhibit reduced cell attachment compared to PLA and may have potential use in biomedical applications.…”
Section: Pharmaceutical and Biomedical Applicationmentioning
confidence: 99%
“…In 1985, Helder et al synthesized polydepsipeptides by ROP of morpholine-2,5-dione derivatives for the first time [36]. Since then, morpholine-2,5-dione derivatives, which have an ester group and an amide group in one six-membered ring, have been used to synthesize various biodegradable copolymers [37][38][39].…”
Section: Introductionmentioning
confidence: 99%